Echelard Yann
SEC insider (Form 3/4/5 filer). CIK 0001561958. Director at TG THERAPEUTICS, INC. (TGTX). 5 reported Form 4/5 transactions since Sep 2024; latest on Jun 11, 2026. Located in MORRISVILLE, NC.
Companies Echelard Yann has filed insider reports for
- TG THERAPEUTICS, INC. (TGTX): Director
Echelard Yann
CIK: 0001561958
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)3 (60.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (40.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
TGTX
TG THERAPEUTICS, INC.
Director
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Jun 11, 2026TGTX
TG THERAPEUTICS, INC.
AwardDirectStock Tracking Unit
8.3K shares- - Nov 24, 2025TGTX
TG THERAPEUTICS, INC.
SaleDirect5K shares at avg. $32.57$163K - Jun 13, 2025TGTX
TG THERAPEUTICS, INC.
SaleDirect10K shares at avg. $36.94$369K - Jun 12, 2025TGTX
TG THERAPEUTICS, INC.
AwardDirect14.7K shares- - Nov 5, 2024TGTX
TG THERAPEUTICS, INC.
SaleDirect20K shares at avg. $24.48$490K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 11, 2026 | TGTX TG THERAPEUTICS, INC. | Award Stock Tracking Unit | 8,325 | - | - | Direct |
| Nov 24, 2025 | TGTX TG THERAPEUTICS, INC. | Sale | 5,000 | $32.57 | $162,850 | Direct |
| Jun 13, 2025 | TGTX TG THERAPEUTICS, INC. | Sale | 10,000 | $36.94 | $369,400 | Direct |
| Jun 12, 2025 | TGTX TG THERAPEUTICS, INC. | Award | 14,718 | - | - | Direct |
| Nov 5, 2024 | TGTX TG THERAPEUTICS, INC. | Sale | 20,000 | $24.48 | $489,600 | Direct |
1-5 of 5 transactions